Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Dr. K.C.J.M (Kathelijne) Kraal

Pediatric oncologist, head of International Patients Unit
Dr. K.C.J.M (Kathelijne) Kraal

My areas of interest are neuroblastoma (NBL) with intraspinal extension and liver tumors. From the SIOPEN I am involved in the neuroblastoma (NBL)- with spinal cord involvement (SCI) registration study. Furthermore, I coordinate multidisciplinary consultation hours for NBL patients with intraspinal extension and survivors. For patients with refractory NBL, I am principal investigator for the VERITAS study (including 131I-MIBG therapy). I am head of the inpatient department for patients with solid tumors and head of the International Office.

Knowledge and experience

Special interests: neuroblastoma, liver tumors and autologous stem cell transplantation.

Working experience

  • 2019 - current: Head clinical solid tumors, Prinses Máxima Centrum, Utrecht.
  • January 2015 - current: Consultant pediatric oncologist, Prinses Máxima Centrum, Utrecht.
  • March 2011- December 2014: Consultant pediatric hemato-oncologist, AMC, Amsterdam.
  • Jan. 2008- March 2011: Consultant pediatric Hemato-oncologist, LUMC, Leiden.
  • Jan. 2007- Jan. 2008: Fellowship Hemato-oncology, LUMC, Leiden
  • Sept. 2005- Aug. 2006: Fellowship Hemato-oncology, LUMC, Leiden.
  • Oct. 2004- Sept. 2005: Fellowship Hemato-oncology, GOSH, Londen.
  • Oct. 2000 – Sept. 2005: Registrar pediatrics, LUMC (Leiden), RdGG (Delft), Great Ormond Street Hospital (GOSH, London).
  • June 1999 –Oct. 2000: senior house-officer pediatrics, Groene Hart Ziekenhuis and Leiden University Medical Centre (LUMC), Leiden, The Netherlands


Professional development

  • Student project Susan Dijkstra: NBL multidisciplinary tumor board and quality of life and use of quality indicators
  • Student Project: Rosa Sledering (NL cohort livertumor patients)
  • Student project: M Rozeman, Autologous stem cell mobilisation and transplantation in paediatric oncology; Poor Mobilisers, successful use of Plerixafor and superior harvest after a single injection of Pegfilgrastim compared to daily Filgrastim. 2020
  • NB congenital-SCI registration study
  • NB-SCI PI registration study
  • 2019: PI VERITAS study, SIOPEN, open December 2019
  • May 2018: Programme Director JACIE autologous stem cell transplantation (JACIE PMC)
  • February 2017: PhD
  • Jan. 2008: Qualified consultant pediatric hemato-oncologist
  • Oct. 2005: Qualified pediatrician
  • July 1999: Qualified Medical doctor
  • Sept. 1993 - July 1999: Medical training (Rijks Universiteit Leiden, the Netherlands)


BIG registration number
69050734801

For a detailed resume and publications, click here.

Contact